These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28190378)

  • 1. Overview of the non-vitamin K oral anticoagulants for atrial fibrillation.
    P Giugliano R
    Ther Adv Cardiovasc Dis; 2017 Mar; 11(3):77-79. PubMed ID: 28190378
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant therapy in atrial fibrillation: vitamin K antagonists or novel oral anticoagulant drugs?
    Riva N; Borg Xuereb C; Ageno W
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):139-41. PubMed ID: 25539157
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation].
    Hohnloser SH
    Herz; 2016 Feb; 41(1):37-47. PubMed ID: 26669316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.
    Turagam MK; Velagapudi P; Flaker GC
    Clin Interv Aging; 2015; 10():1431-44. PubMed ID: 26366064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Stroke prevention in atrial fibrillation.
    Voukalis C; Shantsila E; Lip GY
    J R Coll Physicians Edinb; 2017 Mar; 47(1):13-23. PubMed ID: 28569277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention in atrial fibrillation.
    Freedman B; Potpara TS; Lip GY
    Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulation. Start of a new era?].
    Perrey M; Erbel R
    Herz; 2012 Jun; 37(4):361. PubMed ID: 22669311
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-Vitamin K Antagonist Oral Anticoagulants: The Clinician's New Challenge.
    Yorkgitis BK; Zhang J; Rappold JF
    J Am Osteopath Assoc; 2015 Oct; 115(10):612-21. PubMed ID: 26414714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants.
    Loikas D; Forslund T; Wettermark B; Schenck-Gustafsson K; Hjemdahl P; von Euler M
    Am J Cardiol; 2017 Oct; 120(8):1302-1308. PubMed ID: 28818318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arithmetic of non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation].
    Rubboli A; Vecchio S
    G Ital Cardiol (Rome); 2020 Jul; 21(7):564. PubMed ID: 32555577
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation - Messages from the 2018 EHRA.
    Tomaszuk-Kazberuk A; Kołtowski L; Balsam P; Koziński M; Kapłon-Cieślicka A; Kupczyńska K; Domienik-Karłowicz J; Budaj-Fidecka A; Buszman P; Wybraniec M; Burchardt P; Michalski B; Jaguszewski MJ
    Cardiol J; 2018; 25(4):423-440. PubMed ID: 30211927
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
    Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
    J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New oral anticoagulants versus vitamin K antagonists in countries with good INR control.
    Coppens M
    Neth J Med; 2013 May; 71(4):168-9. PubMed ID: 23723109
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
    Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulants for stroke prevention in atrial fibrillation. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2014 Sep; 39(9):317. PubMed ID: 25194765
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients.
    Scanavacca M; Darrieux F
    Arq Bras Cardiol; 2016 Jan; 106(1):1-3. PubMed ID: 26815647
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Humbert X; Roule V; Chequel M; Fedrizzi S; Brionne M; Lelong-Boulouard V; Milliez P; Alexandre J
    Int J Cardiol; 2016 Nov; 222():1079-1083. PubMed ID: 27514627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence for new oral anticoagulants in the treatment of nonvalvular atrial fibrillation: comparison of substudies.
    Martínez-Rubio A; Martínez-Torrecilla R
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):185-9. PubMed ID: 25449814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.